A world where safe, efficacious therapeutics improve the lives of people with chronic inflammatory diseases.

Our platform allows us to explore cell type and target expression profiles in exquisite detail, both in human cancer and normal tissue samples, as well as disease relevant experimental systems (e.g., human tumor explants, animal models).

Our pioneering Intestinal Microbial Transfer (IMT) therapies are preventing and treating disease, through the restoration and enhancement of gut microbial ecology.

Propelling humanity into a future of preventative health, enabled by seamless access to deep health data in real time.

We’re solving delivery to build the future of RNA therapies—inspired by evolution, perfected with AI.

Scaling regenerative medicine to millions of patients—iDEM™ fully automates manufacture of any human cell type.

Enabling curative cancer treatment through early detection.

Positioned to deliver revolutionary cancer vaccines—using our Infinitopes Precision Immunomics™ pipeline, we can reliably identify highly-expressed and immunogenic tumour antigens presented by cancer cells.

CRIAM is a portable blood testing device for reliable, on-the-spot diagnostics.

Our AI-guided tools support community and family care workers to capture and share precise health measurements enabling more effective care for vulnerable patients.

Simple diagnostic tools for early disease prognosis, diagnosis, and management—Strideing a modular aptamer-based, multiplex lateral flow platform.

Using our AI and integrated wet-laboratory platform we design high-performance aptamers with all the characteristics needed to get a product on the market.

Empowering you and your family to outsmart cancer with an at-home low cost, saliva based lateral flow test to screen for the most common cancers.

Medwise.ai is a customisable search platform designed to help clinicians find the information they need at the point of care.

Exogene is a techbio startup using deep learning to unlock the discovery of innovative TCR-based therapies for cancer treatment.

Instantly validate your surgical trays, instruments, and implants with Scalpel’s computer vision technology.

Unlock the secrets of nature's textile experts, spiders, for a low-cost, low- energy, sustainable biomaterial platform for medical devices.

With Twinn’s advanced AI and MRI technology, your patients gain early insights into potential health risks like cancer, long before symptoms appear.

VisusNano Ltd. is a pre-clinical company Strideing a pipeline of exciting drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery.

We are a female led startup driven by a bold ambition to bring the P4 approach to female health: Personalized, Preventative, Predictive, and Participatory.

We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells.

NanoSyrinx is a discovery stage synthetic biology company creating a next-generation platform technology for the targeted intracellular delivery of biological molecules.

Virtual health support for underserved health journeys.

Personalized birth control and hormonal healthcare for women.

Parkure’s platform opens the door to the discovery of disease modifying drugs for Parkinson’s.

Weaving biology with electronics to produce neurostimulators with unprecedented specificity.

Interactive virtual 3D models to aid medical professionals with treatment planning.